Filing Details

Form Type:
4
Zero Holdings:
No
Publication Time:
2009-08-21 15:49:54
Reporting Period:
2009-08-21
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178711 Transcept Pharmaceuticals Inc TSPT ()
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210529 A Glenn Oclassen C/O Transcept Pharmaceuticals, Inc.
1003 W. Cutting Blvd., Suite #110
Point Richmond CA 94804
Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2009-08-21 8,700 $9.50 35,347 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct